Study finds HIV-specific CD4 cells that control viral levels
A subpopulation of the immune cells targeted by HIV may play an important role in controlling viral loads after initial infection, potentially helping to determine how quickly infection will progress. In the February 29 issue ...
HIV & AIDS
Feb 29, 2012 |
5 / 5 (1) |
0
|
New gene transfer strategy shows promise for limb girdle and other muscular dystrophies
The challenge of treating patients with genetic disorders in which a single mutated gene is simply too large to be replaced using traditional gene therapy techniques may soon be a thing of the past. A Nationwide Children's ...
Genetics
Jul 09, 2012 |
not rated yet |
0
|
Gene therapy reduces HIV levels in small trials
(Medical Xpress) -- This weekend at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Chicago, Illinois, researchers from two different study groups, one on the east coast and one on the west coast, ...
HIV & AIDS
Sep 20, 2011 |
4.8 / 5 (4) |
0
|
Study reveals flu-fighting role for well-known immune component
University of Georgia scientists have discovered a new flu-fighting role for a well-known component of the immune system. Kimberly Klonowski, assistant professor of cellular biology in the UGA Franklin College of Arts and ...
Medical research
Jun 26, 2012 |
5 / 5 (1) |
0
|
Certain mutations give HIV infection an advantage that sticks
(Medical Xpress)—Varieties of HIV that replicate more quickly can cause infected individuals' immune systems to decline faster, new research demonstrates. The results were published by the journal PLOS Pathogens.
HIV & AIDS
Dec 06, 2012 |
5 / 5 (1) |
0
|
Better long-term outcomes with low hep C viral load
(HealthDay)—In patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), low HCV viral load predicts better long-term surgical outcomes, regardless of the serologic eradication of HCV, ...
Diseases, Conditions, Syndromes
Mar 25, 2013 |
not rated yet |
0
Experimental drug may work against hepatitis C
(HealthDay)—An experimental therapy for hepatitis C—a "silent killer" linked to liver cancer and cirrhosis—has shown promise in tamping down virus levels in early trials.
Diseases, Conditions, Syndromes
Mar 27, 2013 |
5 / 5 (3) |
1
|
French patients keep HIV at bay despite stopping drugs (Update)
A small French study of 14 HIV patients who have remained healthy for years after stopping drug treatment offers fresh evidence that early medical intervention may lead to a "functional cure" for AIDS, researchers said Thursday.
HIV & AIDS
Mar 14, 2013 |
not rated yet |
0
Viral load a major factor affecting risk of sexually transmitting HIV
The level of HIV-1 in the blood of an HIV-infected partner is the single most important factor influencing risk of sexual transmission to an uninfected partner, according to a multinational study of heterosexual couples in ...
HIV & AIDS
Jan 12, 2012 |
4.5 / 5 (2) |
0
|
HIV treatment use increases in the US
Between 2000 and 2008, the proportion of HIV-infected patients in the U.S. receiving effective treatment known as highly active antiretroviral therapy (HAART) increased, and HIV-infected patients appeared to be less infectious ...
HIV & AIDS
Sep 03, 2012 |
not rated yet |
0
Patients can emit small, influenza-containing particles into the air during routine care
A new study suggests that patients with influenza can emit small virus-containing particles into the surrounding air during routine patient care, potentially exposing health care providers to influenza. Published in The Journal of ...
Diseases, Conditions, Syndromes
Jan 31, 2013 |
not rated yet |
0
High fever and evidence of a virus? Caution, it still may be Kawasaki disease
Clinicians should take caution when diagnosing a child who has a high fever and whose tests show evidence of adenovirus, and not assume the virus is responsible for Kawasaki-like symptoms. According to a new study from Nationwide ...
Diseases, Conditions, Syndromes
Nov 05, 2012 |
5 / 5 (1) |
0
|
No benefit from high-dose multivitamins seen for HIV patients receiving antiretroviral therapy
A new study by Harvard School of Public Health (HSPH) researchers suggests that, for HIV patients receiving highly active antiretroviral therapy (HAART) to treat HIV, there is no benefit from high- vs. standard-dose micronutrient ...
HIV & AIDS
Oct 16, 2012 |
5 / 5 (1) |
0
|
Combination of oral drugs suppresses common type of hepatitis C
A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.
Diseases, Conditions, Syndromes
Jan 19, 2012 |
not rated yet |
0
|
Non-infected babies born to HIV mothers have reduced immunity to measles
Non-infected babies born to HIV positive mothers should be vaccinated early against measles, to avoid them acquiring the virus or passing it on to others.
HIV & AIDS
Oct 18, 2012 |
not rated yet |
0
